Arwa Bohra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arwa Bohra has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Saurabh Zanwar
Mayo Clinic, Rochester, MN
4 shared publications - Shaji Kumar
Mayo Clinic, Rochester, MN
4 shared publications - Dragan Jevremovic
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
3 shared publications - Sundararajan Vincent Rajkumar
Division of Hematology, Mayo Clinic, Rochester, USA
3 shared publications Wilson I. Gonsalves
3 shared publications- Angela Dispenzieri
Division of Hematology, Mayo Clinic, Rochester, USA
2 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (4)
A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma
- 24 August 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (4)
Open AccessA proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma
- 22 April 2026
- Published by Springer Nature in Leukemia
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myeloma
Multiple myeloma progresses from bone marrow-confined disease to systemic forms through processes linked to loss of adhesion and EMT-related programs. We analyzed baseline plasma cell RNA-seq, microarray, and single-cell datasets to derive and validate a dissemination score. In the newly diagnosed MMRF CoMMpass cohort (n = 754), differential expression analyses of circulating plasma cells (n = 592) and PET-CT-confirmed plasmacytomas (n = 118), integrated with 1114 EMTome genes, identified 1357 dissemination-associated genes. Elastic Net Cox regression derived a 30-gene Dissemination Score (DS) that stratified overall survival (54.5 vs 102.5 mo; C-index 0.71) and improved prognostic performance when added to UAMS70 and EMC92 in bootstrap analyses. DS was associated with Adverse stromal interaction (ASI) and stratified high-risk ASI interactions. In an independent Mayo Clinic cohort (n = 133), DS reproduced prognostic discrimination (52.1 vs 113.6 mo, p < 0.01) and predicted earlier dissemination events (2.1 vs 6.8 yrs, p < 0.01). In GSE117156, circulating plasma cells showed consistently higher DS than marrow plasma cells across MGUS, SMM, MM, and AL, with progressive DS increase from controls to MM. In GSE106218, CD138⁺ extramedullary plasma cells had higher DS than marrow plasma cells (p < 0.01). Collectively, DS quantifies dissemination biology.
- 22 April 2026
- Published by Springer Nature in Leukemia
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myeloma
Multiple myeloma progresses from bone marrow-confined disease to systemic forms through processes linked to loss of adhesion and EMT-related programs. We analyzed baseline plasma cell RNA-seq, microarray, and single-cell datasets to derive and validate a dissemination score. In the newly diagnosed MMRF CoMMpass cohort (n = 754), differential expression analyses of circulating plasma cells (n = 592) and PET-CT-confirmed plasmacytomas (n = 118), integrated with 1114 EMTome genes, identified 1357 dissemination-associated genes. Elastic Net Cox regression derived a 30-gene Dissemination Score (DS) that stratified overall survival (54.5 vs 102.5 mo; C-index 0.71) and improved prognostic performance when added to UAMS70 and EMC92 in bootstrap analyses. DS was associated with Adverse stromal interaction (ASI) and stratified high-risk ASI interactions. In an independent Mayo Clinic cohort (n = 133), DS reproduced prognostic discrimination (52.1 vs 113.6 mo, p < 0.01) and predicted earlier dissemination events (2.1 vs 6.8 yrs, p < 0.01). In GSE117156, circulating plasma cells showed consistently higher DS than marrow plasma cells across MGUS, SMM, MM, and AL, with progressive DS increase from controls to MM. In GSE106218, CD138⁺ extramedullary plasma cells had higher DS than marrow plasma cells (p < 0.01). Collectively, DS quantifies dissemination biology.
- 25 February 2026
- Published by Springer Nature in Leukemia
- Vol. 40 (4) , 854
Correction: Peripheral blood flow cytometry-based definition of plasma cell leukemia
- 25 February 2026
- Published by Springer Nature in Leukemia
- Vol. 40 (4) , 854
Correction: Peripheral blood flow cytometry-based definition of plasma cell leukemia
- 26 May 2025
- Published by Springer Nature in Leukemia
- Vol. 39 (8) , 2039-2041
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia
- 26 May 2025
- Published by Springer Nature in Leukemia
- Vol. 39 (8) , 2039-2041
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia
- Open Access
- 9 September 2024
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 46 (5) , 417-424
Training Needs Analysis for Medical Students in Assessing Cognitive Functioning: An Observational Study
Backgrounds: Research shows that medical students’ knowledge and skills concerning the assessment of cognition in various neuropsychiatric conditions (e.g., Alzheimer’s disease and schizophrenia) are unsatisfactory. This research aims to conduct a training needs analysis (TNA) for medical students to identify and refer patients with neuropsychiatric conditions. Methods: The study comprised two phases. First, developing a TNA toolkit to assess training needs in clinical tasks related to cognitive function assessment (by adopting the Hennessy–Hicks TNA toolkit); and second, through a self-reported survey, their training needs in cognitive function assessment were assessed. Data analysis involved calculating training gaps, importance scores, performance scores, training scores, and organization scores for various clinical tasks-stratified participants’ study year; for training needs and trends, factor analysis and post-hoc analyses were conducted. Results: A total of 153 medical students from a tertiary care center participated in the survey. The participants rated their performance lower than the perceived importance of tasks, indicating a need for improvement in all competencies ( P < .01). Pre–final-year students had the highest training needs, particularly in accessing literature, planning, and organizing care for patients with cognitive impairment, performing mental status examination, screening patients for cognitive deficits, and counseling them/caregivers about interventions ( P < .01). Factor analysis identified a single dominant factor, suggesting a correlation among these skills. Conclusion: Pre–final-year students require targeted training, whereas students beyond this stage can benefit from special training modules and awareness of available resources for cognitive assessment. The findings also suggest the importance of a hybrid approach involving training and organizational modifications.
- 9 September 2024
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 46 (5) , 417-424
Open AccessTraining Needs Analysis for Medical Students in Assessing Cognitive Functioning: An Observational Study
Backgrounds: Research shows that medical students’ knowledge and skills concerning the assessment of cognition in various neuropsychiatric conditions (e.g., Alzheimer’s disease and schizophrenia) are unsatisfactory. This research aims to conduct a training needs analysis (TNA) for medical students to identify and refer patients with neuropsychiatric conditions. Methods: The study comprised two phases. First, developing a TNA toolkit to assess training needs in clinical tasks related to cognitive function assessment (by adopting the Hennessy–Hicks TNA toolkit); and second, through a self-reported survey, their training needs in cognitive function assessment were assessed. Data analysis involved calculating training gaps, importance scores, performance scores, training scores, and organization scores for various clinical tasks-stratified participants’ study year; for training needs and trends, factor analysis and post-hoc analyses were conducted. Results: A total of 153 medical students from a tertiary care center participated in the survey. The participants rated their performance lower than the perceived importance of tasks, indicating a need for improvement in all competencies ( P < .01). Pre–final-year students had the highest training needs, particularly in accessing literature, planning, and organizing care for patients with cognitive impairment, performing mental status examination, screening patients for cognitive deficits, and counseling them/caregivers about interventions ( P < .01). Factor analysis identified a single dominant factor, suggesting a correlation among these skills. Conclusion: Pre–final-year students require targeted training, whereas students beyond this stage can benefit from special training modules and awareness of available resources for cognitive assessment. The findings also suggest the importance of a hybrid approach involving training and organizational modifications.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine Approach
Background: SARS-CoV-2 Virus can trigger severe pneumonia and lead to acute respiratory distress syndrome. Data from clinical, in vitro, and in vivo suggest that virus-induced cytokine dysregulation is a contributory factor to the pathogenesis. Drugs targeting the same are being tried. Methods: To obtain a better understanding of the molecular events, we studied the transcriptome of infected macrophages and obtained a list of incriminated pathways using Gene Set Enrichment Analysis. Co-expression gene analysis was further used to predict drug targets. Results: COVID-19 is characterized by a dysregulation of not only immune pathways, but of hemostasis, intercellular signaling, endothelium, cellular protein metabolism, trans-cellular transport and neuronal activity. Interferon alpha, beta, and gamma are upregulated. IL-1,4, 6,10, 12 13, TNF, NF-KB are upregulated. Signaling by NOTCH, and MAP kinase-6, 4 signaling are increased. Olfactory sensation, transmission across chemical synapses, and sperm motility appear to be downregulated. Disease host signature has some resemblance with cystic fibrosis, SARS infection, and diseases of programmed cell death like neurodegenerative diseases. 24 drugs are predicted including Sulindac, Pancuronium, Etamsylate, Ciclosporin, Ciprofloxacin, Valproic Acid, Triamcinolone, Tanespimycin, Tretinoin, Monorden, Scopolamine, Captopril, and Thalidomide. Conclusions: The effectiveness of this approach is demonstrated by the current level of evidence in understanding of COVID-19 pathophysiology. Several drugs of the same drug class have been used in COVID-19 treatment as predicted through the analysis. Further biomarker studies, drug testing on COVID infected cell-lines, and clinical studies are required for validation of obtained results.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessTranscriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine Approach
Background: SARS-CoV-2 Virus can trigger severe pneumonia and lead to acute respiratory distress syndrome. Data from clinical, in vitro, and in vivo suggest that virus-induced cytokine dysregulation is a contributory factor to the pathogenesis. Drugs targeting the same are being tried. Methods: To obtain a better understanding of the molecular events, we studied the transcriptome of infected macrophages and obtained a list of incriminated pathways using Gene Set Enrichment Analysis. Co-expression gene analysis was further used to predict drug targets. Results: COVID-19 is characterized by a dysregulation of not only immune pathways, but of hemostasis, intercellular signaling, endothelium, cellular protein metabolism, trans-cellular transport and neuronal activity. Interferon alpha, beta, and gamma are upregulated. IL-1,4, 6,10, 12 13, TNF, NF-KB are upregulated. Signaling by NOTCH, and MAP kinase-6, 4 signaling are increased. Olfactory sensation, transmission across chemical synapses, and sperm motility appear to be downregulated. Disease host signature has some resemblance with cystic fibrosis, SARS infection, and diseases of programmed cell death like neurodegenerative diseases. 24 drugs are predicted including Sulindac, Pancuronium, Etamsylate, Ciclosporin, Ciprofloxacin, Valproic Acid, Triamcinolone, Tanespimycin, Tretinoin, Monorden, Scopolamine, Captopril, and Thalidomide. Conclusions: The effectiveness of this approach is demonstrated by the current level of evidence in understanding of COVID-19 pathophysiology. Several drugs of the same drug class have been used in COVID-19 treatment as predicted through the analysis. Further biomarker studies, drug testing on COVID infected cell-lines, and clinical studies are required for validation of obtained results.